Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lymphoma, Follicular × Tea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 10 Lung Neoplasms 4 Pancreatic Neoplasms 3 Pain, Postoperative 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Male Urogenital Diseases 2 Leiomyoma 2 Inflammation 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Skin Neoplasms 1 Shoulder Pain 1 Psychological Well-Being 1 Postoperative Complications 1 Post-thoracotomy Pain Syndrome 1 Neoplasms 1 Mouth Neoplasms 1 Motor Activity 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lung Cancer Prevention 1 Liver Neoplasms 1 Inflammatory Bowel Diseases 1

Interventions

Rituximab 246 Cyclophosphamide 209 fludarabine phosphate 89 Peripheral Blood Stem Cell Transplantation 89 Filgrastim 80 Etoposide 74 Radiotherapy 70 Lenalidomide 69 Vincristine 68 Prednisone 68 Doxorubicin 55 Bendamustine Hydrochloride 54 Mycophenolic Acid 53 Whole-Body Irradiation 51 Cyclosporine 50 fludarabine 46 Melphalan 45 Tacrolimus 41 Cytarabine 41 Busulfan 40 obinutuzumab 39 Methotrexate 38 Antilymphocyte Serum 34 Methylprednisolone 31 Carmustine 30 Bortezomib 29 sargramostim 27 ibritumomab tiuxetan 27 Dexamethasone 27 ibrutinib 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡